These results, reported in the October 1 issue of the Journal of Clinical Investigation, demonstrate that a therapeutic window of opportunity may exist in which a single dose of EPO following myocardial infarct, cardiac surgery or other acute coronary syndromes may offer acute protection as well as long term preservation of the ischemic and infarcted heart.
TITLE: A novel protective effect of erythropoietin in the infarcted heart
AUTHOR CONTACT:
Walter J. Koch
Jefferson Medical College, Philadelphia, Pennsylvania, USA.
Phone: 215-955-9982
Fax: 215-955-1690
E-mail: walter.koch@jefferson.edu
View the PDF of this article at: http://www.jci.org/cgi/content/full/112/7/999
Journal of Clinical Investigation